Real-time enrollment status for this stage ii rectal cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 12:11 PM UTC
| NCT Number | NCT03051464 |
| Recruiting Status | Recruiting |
| Condition | Stage II Rectal Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 131 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Sir Mortimer B. Davis - Jewish General Hospital |
| Last Updated on CT.gov | June 30, 2026 (1 week ago) |
As of July 13, 2026: Clinical trial NCT03051464 is currently recruiting participants. This clinical trial study for stage ii rectal cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by Sir Mortimer B. Davis - Jewish General Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03051464 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03051464 was last updated 1 week ago (June 30, 2026). HelloStudys verifies this status automatically.